Most Read Articles
Stephen Padilla, 25 Jul 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
Rachel Soon, 05 Dec 2018

At the recent Malaysian Community Pharmacy Business Forum (MyCPBF), a discussion forum was held on the subject of “Transcending Primary Healthcare Services: The Future of Specialized Pharmacy Services and Pharmacy Specialization”.

12 Dec 2016

Associate Professor Ng Lee Ching, Director of the Environmental Health Institute (EHI) at the National Environment Agency (NEA), Singapore, speaks about the role of primary care physicians and government agencies in preventing dengue epidemics.

22 Aug 2018
In patients with atrial fibrillation (AF) naïve to oral anticoagulants (OACs), standard-dose nonvitamin K antagonist OACs (NOACs) provides better survival benefits than warfarin, a recent meta-analysis has shown.

Systematic medication therapy management improves CMR completion rate in community pharmacy

4 days ago
Pharmacists’ dual identity of the community they serve: A patient in need of professional care is also a paying customer who sustain the business.

Implementing a systematic approach for medication therapy management (MTM) in a community pharmacy setting may help improve the completion rate of a comprehensive medication review (CMR), suggests a recent study.

The investigators sought to determine how implementing a systematic MTM process impacted CMR completion rates in this process improvement pilot, which included four grocery store-based community pharmacy sites.

Site staff underwent training on a systematic process to integrate OutcomesMTM opportunities into their pharmacy workflow. Technicians prepared MTM paperwork, including a standardized CMR worksheet, which is used by pharmacists to deliver the service at the counsel window.

The change in CMR completion rate from pre- to postimplementation, with each site serving as its own control, was the primary outcome. Secondary outcomes included change in targeted intervention programme (TIP) completion rate and survey results assessing barriers and feasibility.

An improvement was observed in the mean completion rate of CMR from 2.7±5.4 percent to 23.2±7.7 percent (p<0.10). The mean TIP completion rate also improved from 3.4±4.2 percent to 24.9±19.2 percent (p<0.10) pre- to postimplementation.

In addition, survey results revealed that pharmacists were satisfied with the systematic approach. The most significant barriers were as follows: documentation, claim submission and time spent contacting prescribers.

This study, however, had certain limitations, such as its small sample size. Thus, the results and process may not be generalizable to other sites, according to the investigators.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 25 Jul 2019
Nonvitamin K antagonist oral anticoagulants (NOACs) appear to confer more clinical benefits to elderly patients with atrial fibrillation (AF) than vitamin K antagonist anticoagulants (VKAs), suggests a study, adding that this is primarily driven by the lower rates of major bleeding.
Rachel Soon, 05 Dec 2018

At the recent Malaysian Community Pharmacy Business Forum (MyCPBF), a discussion forum was held on the subject of “Transcending Primary Healthcare Services: The Future of Specialized Pharmacy Services and Pharmacy Specialization”.

12 Dec 2016

Associate Professor Ng Lee Ching, Director of the Environmental Health Institute (EHI) at the National Environment Agency (NEA), Singapore, speaks about the role of primary care physicians and government agencies in preventing dengue epidemics.

22 Aug 2018
In patients with atrial fibrillation (AF) naïve to oral anticoagulants (OACs), standard-dose nonvitamin K antagonist OACs (NOACs) provides better survival benefits than warfarin, a recent meta-analysis has shown.